Navigation Links
Solta Medical Reports Third Quarter 2009 Results
Date:11/3/2009

HAYWARD, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced results for the third quarter ended September 30, 2009. Revenue for the quarter was in-line with the preliminary forecast provided on September 28th.

Revenue for the third quarter was $17.8 million, an increase of approximately $4.7 million, or 36%, as compared to the third quarter 2008 reflecting increased revenue as a result of the acquisition of Reliant Technologies, Inc. on December 23, 2008, and partially offset by production and regulatory approval delays on new products during the third quarter.

"As we have previously disclosed, we received 510K clearance for the Fraxel re:store DUAL system in mid-October and resolved our production delays on the Thermage CPT system at the end of the third quarter. We are fulfilling back orders from customers and shipping both products," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical. "Our illumiNATION tour continues to bring these latest breakthroughs in Thermage and Fraxel systems directly to physicians as it makes it way from city-to-city across the U.S. and Europe. The tour has generated a very enthusiastic response to our new products by physicians, prospective patients, and the media. As a result, we are gaining momentum in the market place," added Mr. Fanning.

Solta Medical's reported results for the third quarter of 2009 include non-cash purchase price related charges, primarily amortization of acquired intangible assets, of $1.2 million and non-cash stock based compensation charges of $0.8 million. The GAAP net loss for the quarter including these charges was $6.2 million, or $0.13 per share as compared to a net loss of $1.1 million, or $0.05 per share reported for the third q
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
2. Solta Medical to Present at the Maxim Group Growth Conference
3. Solta Medical Launches illumiNATION tour in U.S. and Europe to Introduce New Thermage CPT(TM) and Fraxel re:store(R) Dual Systems
4. Solta Medical Launches New Fraxel re:store(R) Dual Laser System
5. Solta Medical Reports Strong Second Quarter 2009 Results
6. Solta Medical, Inc. Announces Second Quarter 2009 Results Release Date and Conference Call
7. Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank
8. Solta Medical, Inc. to Present at 8th Annual Needham Life Sciences Conference
9. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
10. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
11. Solta Medical Presents Expert Roundtable about Thermage(R) and Fraxel(R) Combination Treatments at ASLMS Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... CLEVELAND -- December 16, 2009 -- Every year ... are diagnosed, and 57,000 patients die of the disease, ... cancer among adults, after lung cancer. , As researchers ... colorectal cancer -- simultaneously generating thousands of studies producing ... professor and researcher of cancer and genetics at Case ...
(Date:12/16/2009)... For wounded U.S. servicemen and women recovering at Walter ... can be a particularly difficult time. Wounded soldiers ... ever on the healing power of connecting with family ... easier for Walter Reed patients as Verizon Wireless donated ... of minutes of holiday talk time for 2,500 recovering ...
(Date:12/16/2009)... that increase susceptibility to disease , , WEDNESDAY, Dec. ... increased susceptibility to leprosy have been identified by ... who analyzed more than 10,000 DNA samples from ... their discovery highlights the important role that the ... leprosy. , "Though leprosy is not common, the ...
(Date:12/16/2009)... commonly found in fatty fish and algae help ... by the American Psychological Association. The finding connects ... people with schizophrenia; bipolar, obsessive-compulsive, and attention-deficit hyperactivity ... nervous system. , The study, reported in ... evidence that fish is brain food. The key ...
(Date:12/16/2009)... of Digital Pen and Paper technology and the provider of ... announced that it is ranked among the Fastest Growing Technology ... , ... (PRWEB) December 16, 2009 ... the capture, digitalization and management of handwritten data. Kayentis targets ...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:Leprosy Genes Identified 2Health News:New study links DHA type of omega-3 to better nervous-system function 2Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2
... could not only make you loose your sight but even your ... the eye may have to be removed. ,Researchers at the ... plasma to shoot tiny bullets of blockage-dissolving drugs into a ... the retina drain into a single vein. "If this central vein ...
... Complication as its other name. Among the many complications that ... ulcer, as damage can be severe enough to require amputation. ... in disguise would be a new device that delivers a ... stimulation would help in the healing of foot ulcers. ...
... basis. One of these latest laser techniques is helpful in ... This degenerative condition cause blood vessels to grow underneath the ... ,Eye specialists have come up with a new therapy ... of damaging the retinal tissue. ,This is a two-step ...
... to strike a pot of gold by making cheap ... is likely to escalate in coming days. ,The ... to develop anti-AIDS drugs and market it in India ... ,The anti-AIDS drug market, currently dominated by Mumbai-based Cipla, ...
... of Bihar were facing the worst forms of nightmare over ... political scenario but the threat of malaria . ,Malaria ... invaded the tribal areas of Munger, 200 km (125 miles) ... died of cerebral malaria in this eastern Indian state of ...
... of the American Journal of Epidemology, moderate levels of ... According to Dr. Susanne Hoidrup from Glostrup University Hospital, ... process, regular physical activity should become an essential part ... increase in hip fractures. ,In the study, ...
Other Medicine News:Health News:Blocked viens block eye sight 2
(Date:12/16/2009)... -- Cohera Medical Inc. today announced the treatment ... its lead surgical adhesive product, TissuGlu®. Initiation of ... company,s progression of the lead product toward clinical ... prospective, open-label, randomized study to investigate the safety ... and associated complications in abdominoplasty, or "tummy tuck," ...
(Date:12/16/2009)... According to Millennium Research Group (MRG), the global ... reforms in China supported rapid expansion of the ... continue to fuel growth in the coming years. ... Interventional Cardiology Devices 2010 report finds that ... the Chinese drug-eluting stent market to reach a ...
(Date:12/16/2009)... December 16 Today, Avantium announced ... Officer of its pharmaceutical,business. Gunnar Staaf previously ... Eli Lilly & Company, in a range ... an important step in Avantium,s plan to,spin-out ... create a,stand-alone pharmaceutical company based on its ...
Breaking Medicine Technology:First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Avantium Appoints Gunnar Staaf as CEO Pharma 2Childbirth May Slow Progression of Multiple Sclerosis 62015 1Childbirth May Slow Progression of Multiple Sclerosis 62015 2Childbirth May Slow Progression of Multiple Sclerosis 62015 3DNA Genotek Launches Global Partner Program 14953 1DNA Genotek Launches Global Partner Program 14953 2DNA Genotek Launches Global Partner Program 14953 3Jackson 26amp 3B Coker Industry Report Addresses Health Care Reform 62010 1Jackson 26amp 3B Coker Industry Report Addresses Health Care Reform 62010 2Jackson 26amp 3B Coker Industry Report Addresses Health Care Reform 62010 3
... Australia, Jan. 22 A new world-first study,by ... has a,profound impact on one of society,s biggest ... today in Journal of the American Medical,Association (JAMA), ... underwent,gastric banding were five times more likely to ...
... Contracts Give Access to Diagnostic Application of Research ... Coulter,Inc. (NYSE: BEC ) announced today that ... Ireland, Galway (NUI Galway) to direct assay,research and ... of infectious disease tests for the company,s future ...
Other Medicine Technology:Gastric Banding Reverses Impact of Type 2 Diabetes 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 3
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
Anti-Rotavirus Antigen Assay (ELISA)....
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
... Acolytes core technology relates to the ... enzyme found in all living cells. ... measured using bioluminescence. By coupling ... example via extraction using antibody-coated beads, Acolyte ...
Medicine Products: